SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-074605
Filing Date
2014-10-29
Accepted
2014-10-29 08:49:29
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19628_110q.htm 10-Q 1176038
2 EX-10.1 a14-19628_1ex10d1.htm EX-10.1 51433
3 EX-31.1 a14-19628_1ex31d1.htm EX-31.1 22241
4 EX-31.2 a14-19628_1ex31d2.htm EX-31.2 22536
5 EX-32.1 a14-19628_1ex32d1.htm EX-32.1 8720
  Complete submission text file 0001104659-14-074605.txt   7110401

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alks-20140930.xml EX-101.INS 1170032
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20140930.xsd EX-101.SCH 38224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alks-20140930_cal.xml EX-101.CAL 67727
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alks-20140930_def.xml EX-101.DEF 103130
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT alks-20140930_lab.xml EX-101.LAB 407734
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20140930_pre.xml EX-101.PRE 274954
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 141178749
SIC: 2834 Pharmaceutical Preparations